The vascular dilatation induced by Hydroxysafflor yellow A (HSYA) on rat mesenteric artery through TRPV4-dependent calcium influx in endothelial cells. (28th June 2020)

• Record Type: Journal Article
• Authors: Yang, Jianfeng; Wang, Rui; Cheng, Xiaohan; Qu, HuiChong; Qi, Jing; Li, Dan; Xing, Yan; Bai, Yuhua; Zheng, Xiaodong
• Is Part Of: Journal of ethnopharmacology. Volume 256(2020)
• Publication Date: 2020-06-28
• Subjects: HSYA -- Vascular dilatation -- Calcium influx -- Endothelial cells -- Protein kinase A -- TRPV4; HSYA -- PubChem CID: 6443665; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2020.112790
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological relevance: Hydroxysafflor yellow A (HSYA) is the principal constituent of the flowers of Carthamus tinctorius L., a traditional Chinese herbal medicine, which has been used for the treatment of cerebrovascular and cardiovascular diseases due to its property of promoting blood circulation and removing blood stasis. It is dominated in the water extract of Carthamus tinctorius L., which has been used in the clinical treatment for cardiovascular diseases. HSYA exerts a variety of pharmacological efficacy upon the vascular system. However, the underlying mechanisms remain unclear. Aim of the study: To investigate the vascular dilatation effect of HSYA on rat mesenteric artery (MA) and its potential mechanism. Materials and methods: Adult male Wistar rats were applied to the study. Tension studies were conducted to determine the dilatation activity of HSYA against pre-contracted mesenteric arterial (MA) rings by U 46619 and Phenylephrine (PE). The vascular activities were measured with or without incubation with some selective inhibitors, including L-N(ω)-nitro-L-arginine methyl ester (L-NAME, a nitro oxide synthase inhibitor), HC-067047 (a selective TRPV4 antagonist), BaCl2 (a Kir channel blocker), and Indomethacin (Indo, a nonselective cyclooxygenase inhibitor), respectively. Immunocytochemistry, Calcium Imaging, NO Production detection, and Western Blot were also employed to further study the underlying mechanism. Results: HSYA reversed the constriction of MAs induced by U 46619 in a manner of concentration dependency, and the dilatation capability was reversed by L-NAME. This effect was significantly dependent on the intactness of MA endothelium, accompanying an increment of NO production in mesenteric arterial endothelium cells. The increment of NO production was reversed by inhibiting the PKA. Also, the expression of p-eNOS was activated by HSYA shown in Western Blot assays. The cells imaging revealed a significant increase and drop of the influx of Ca 2+ before and after treatment with HC-067047. Conclusions: These findings suggest that HSYA exerts vessel dilation effect on MAs via a TRPV4-dependent influx of Ca 2+ in endothelium cells, PKA-dependent eNOS phosphorylation and NO production mechanism. The present study indicates that HSYA has the potential to be a future candidate for the treatment of hypertension. Graphical abstract: Image 1 Highlights: In this article, we studied the mechanism of vasodilation of mesenteric artery by HSYA. The relaxant effect of HSYA on mesenteric artery is related to endothelial cells. For the first time we found that HSYA relax the mesenteric artery via a TRPV4-dependent influx of Ca 2+ in endothelium cells and PKA-dependent eNOS phosphorylation and NO production.